ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
Dow Jones
39,069.59
0.01%
Brent Oil
82.005
0.03%
Bitcoin
68,740.31
0.34%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vor Biopharma Inc (VOR)

  7. Vor Biopharma Inc (VOR) News

VOR

Vor Biopharma (VOR)

Vor Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VOR
DateTimeSourceHeadlineSymbolCompany
05/09/20244:05PMGlobeNewswire Inc.Vor Bio Reports First Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
05/09/20244:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
05/07/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
05/07/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
05/06/20248:00AMGlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
05/03/20244:01PMGlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
05/02/20244:01PMGlobeNewswire Inc.Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of DirectorsNASDAQ:VORVor Biopharma Inc
04/01/20248:00AMGlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
03/20/20244:05PMGlobeNewswire Inc.Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
03/05/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
03/05/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
03/05/20244:01PMGlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
03/04/20248:00AMGlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
02/14/20244:08PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VORVor Biopharma Inc
02/08/20245:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
02/08/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
02/07/20248:00AMGlobeNewswire Inc.Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:VORVor Biopharma Inc
02/02/20244:01PMGlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
01/31/20247:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
01/31/20247:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
01/17/20244:01PMGlobeNewswire Inc.Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate UpdateNASDAQ:VORVor Biopharma Inc
01/05/20245:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
12/21/20234:01PMGlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
12/01/20234:01PMGlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
11/27/20238:00AMGlobeNewswire Inc.Vor Bio to Participate in the JMP Securities Hematology and Oncology SummitNASDAQ:VORVor Biopharma Inc
11/09/20234:01PMGlobeNewswire Inc.Vor Bio Presents Positive Data Update on Trem-cel at HSCT² ConferenceNASDAQ:VORVor Biopharma Inc
11/08/20234:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
11/08/20234:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
11/07/20234:05PMGlobeNewswire Inc.Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
11/07/20234:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:VOR

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
DJT
Trump Media and Technology
USOTC
MGON
Megola (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
AMRN
Amarin
USOTC
RDGL
Vivos (QB)
USOTC
DPLS
DarkPulse (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
RONN
Ronn Motor (PK)
USOTC
SPZI
Spooz (PK)
NASDAQ
NVDA
NVIDIA
USOTC
NSAV
Net Savings Link (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
RNVA
Rennova Health (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved